Literature DB >> 2752859

A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial.

J A Reis Neto1, F A Quilici, J A Reis.   

Abstract

From 1978 to 1980, 68 patients with rectal cancer were randomly allocated to either preoperative irradiation plus surgery or surgical treatment without any preoperative measures. The primary aim of the trial was to investigate the 5-year survival rate in both groups; a secondary aim was to analyze the local recurrence rate and finally the anatomopathologic tumoral classification after surgery. All patients were followed at least 8 years. The preoperative irradiation group (Group A) was submitted to 4000 cGy for 4 weeks and surgery was performed 1 week after irradiation. All tumors were classified anatomically and pathologically according to Broders' and Dukes' classifications. The results indicated that there is a significant difference in the five-year survival rates in both groups: group A had a corrected survival rate of 80 percent; group B (nonirradiated) had a corrected survival rate of 80 percent; group B (nonirradiated) had a corrected survival rate of 34.4 percent. The local recurrence rate was 2.9 percent in group A and 23.5 percent in group B. Regarding tumor regression, before radiotherapy 64.6 percent of the tumors were Broders' Grades 3 and 4; after radiotherapy these were reduced to 20.5 percent. As to Dukes' classification, 26.4 percent of the tumors were type C in group A and, in group B, 47 percent were considered as Dukes' C.

Entities:  

Mesh:

Year:  1989        PMID: 2752859     DOI: 10.1007/bf02555778

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

Review 1.  Optimising treatment for resectable rectal cancer: is preoperative therapy beneficial?

Authors:  S Y Ngan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Improved outcome following preoperative radiochemotherapy: 40.5 Gy accelerated hyperfractionation and 5-fluorouracil suppositories for patients with carcinoma of the lower rectum.

Authors:  H Horie; H Kashiwagi; F Konishi; K Furuta; A Ozawa; K Kanazawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Management of colorectal cancer.

Authors:  A Melville; T A Sheldon; R Gray; A Sowden
Journal:  Qual Health Care       Date:  1998-06

4.  The effects of hyperbaric oxygen therapy on experimental colon anastomosis after preoperative chemoradiotherapy.

Authors:  Ramazan Yildiz; Mehmet Fatih Can; Gokhan Yagci; Taner Ozgurtas; Metin Guden; Mehmet Gamsizkan; Erkan Ozturk; Sadettin Cetiner
Journal:  Int Surg       Date:  2013 Jan-Mar

5.  Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer?

Authors:  W M Mendenhall; K I Bland; E M Copeland; G E Summers; W W Pfaff; W W Souba; R R Million
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

6.  Recent advances in the treatment and outcome of locally advanced rectal cancer.

Authors:  J N Vauthey; R W Marsh; R A Zlotecki; E K Abdalla; C C Solorzano; E J Bray; M E Freeman; G Y Lauwers; P S Kubilis; W M Mendenhall; E M Copeland
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

Review 7.  Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions.

Authors:  Lutz Moser; Jörg-Peter Ritz; Wolfgang Hinkelbein; Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2007-12-07       Impact factor: 2.571

Review 8.  [Indications for neoadjuvant therapy in rectal carcinoma].

Authors:  F Zimmermann; M Molls
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

9.  Laparoscopic total mesorectum excision.

Authors:  J A Reis Neto; F A Quilici; F Cordeiro; J A Reis; O Kagohara; J Simões Neto
Journal:  JSLS       Date:  2002 Apr-Jun       Impact factor: 2.172

10.  Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma.

Authors:  Iosief Abraha; Cynthia Aristei; Isabella Palumbo; Marco Lupattelli; Stefano Trastulli; Roberto Cirocchi; Rita De Florio; Vincenzo Valentini
Journal:  Cochrane Database Syst Rev       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.